Hypertension. Essential (primary) hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Men and women aged 30-65 years Hypertension grade1 with pressure equal to or greater than 140.90 mmHg to 159.99 mmHg Are treated with a blood pressure medication (one to three drugs based on the protocol). BMI greater than or equal to 27 At least one month has passed since starting the medication The person should not be at high risk (diabetes mellitus and end organ damage , etc.)
Exclusion criteria
Exclusion criteria: History of hypo or hyperthyroidism Types of cardiac dysrhythmias (such as second and third degree block) Allergy to medicinal plants History of potassium greater than 5.1 or less than 3.5 m Eq / L at the first visit Warfarin consumption Pregnancy or lactation History of hypermenorrhea in females Presence of blood pressure greater than or equal to 180/110 mm Hg The presence of any medical or surgical disorder that could interfere with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: In baseline and after 4 week and after 8 week. Method of measurement: Sphygmomanometer.;FBS, BUN, Cr, TG, Cholesterol, SGOT, SGPT, CBC. Timepoint: Beginning and end of the study (after 8 weeks). Method of measurement: Biochemical and Hematological blood check. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score. Timepoint: pretest, post-test (at the end of 8 weeks). Method of measurement: The World Health Organization Quality of Life Questionnaire.;Stress, Anxiety and Depression score. Timepoint: pretest, post-test (at the end of 8 weeks). Method of measurement: DASS21 Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences